CellDrop Biosciences Inc., a University of Wyoming spinout company developing advanced cell-processing technologies, has ...
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western ...
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in western ...
A new review was published in Volume 18 of Aging on May 30, 2026, titled "The love and hate relationship between cellular ...
After a double whammy blow, Cynata is “actively reviewing” alternative uses for its Cymerus platform technology. ... Read ...
MuseCell Innovations (MCI), the exclusive global licensor of Dezawa MuseCells®, today announced its U.S. launch. By making this restorative therapy available domestically, MCI eliminates the need for ...
Money.ca on MSN
Stem-cell tourism is costing Canadians tens of thousands — and more, especially when multiple risks can outweigh the results
From TikTok testimonials to $30,000 trips abroad, more Canadians are chasing experimental treatments that Health Canada ...
Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...
Vascular disease represents a major contributor to global cardiovascular mortality, characterized by structural and ...
Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to ...
A new experimental model has illustrated how NF-1 tumors progress. Researchers have used the model for high-throughput ...
US startup Wildtype has kicked off a crowdfunding round to begin direct-to-consumer sales of its cultivated salmon lox and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results